Octreotide Acetate recalls

5 recalls on record

Recalled by 1 agency: FDA (5).

First recall on record: November 16, 2022. Most recent: May 13, 2026.

Risk classification: Class I: 1 · Class II: 4

Recalert records 5 recalls for Octreotide Acetate from FDA. The earliest is dated November 16, 2022 and the latest May 13, 2026. 4 recalls are dated within the last 12 months. The most frequent categories are drug. The latest recall is Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, In Single-Dose kits containing: 8-mL vial of 30 mg strength, a pre-filled syringe containing 2 mL of diluent, one vial adapter, and one sterile 1® 19-gauge safety injection needle, Rx only, Manufactured in Greece BY: Pharmathen International S.A, Rodopi, 69300 Greece, Manufactured For: TEVA Pharmaceuticals, Parsippany, NJ 07054. NDC Kit Carton: 0480-9262-08; Vial Label: 0480-9260-01; Tray Label: 0480-9262-08; Diluent Label: 0480-9263-21. (D-0519-2026).

Most recent recalls

Questions about this brand

Does Octreotide Acetate have recalls in 2026?
Recalert records 4 recalls for Octreotide Acetate dated in 2026.

Do you sell Octreotide Acetate products? Check your whole catalog free against 80,000+ recalls.

Paste up to 100 UPCs or SKUs and see which ones match a CPSC, FDA, NHTSA or FSIS recall. No account needed.

Check my catalog free

Want it checked every night instead? Starter watches 500 SKUs for $29/month. See plans

Related brands